Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4J26

Estrogen Receptor in complex with proline-flanked LXXLL peptides

4J26 の概要
エントリーDOI10.2210/pdb4j26/pdb
関連するPDBエントリー3OLL 4J24
分子名称Estrogen receptor beta, 12-mer Peptide, ESTRADIOL, ... (4 entities in total)
機能のキーワードestrogen receptor, proline, lxxll, alpha-helix, structure stabilization, hormone receptor-peptide complex, hormone receptor/peptide
由来する生物種Homo sapiens (human)
詳細
細胞内の位置Nucleus: Q92731
タンパク質・核酸の鎖数4
化学式量合計57672.62
構造登録者
主引用文献Fuchs, S.,Nguyen, H.D.,Phan, T.T.,Burton, M.F.,Nieto, L.,de Vries-van Leeuwen, I.J.,Schmidt, A.,Goodarzifard, M.,Agten, S.M.,Rose, R.,Ottmann, C.,Milroy, L.G.,Brunsveld, L.
Proline primed helix length as a modulator of the nuclear receptor-coactivator interaction
J.Am.Chem.Soc., 135:4364-4371, 2013
Cited by
PubMed Abstract: Nuclear receptor binding to coactivator proteins is an obligate first step in the regulation of gene transcription. Nuclear receptors preferentially bind to an LXXLL peptide motif which is highly conserved throughout the 300 or so natural coactivator proteins. This knowledge has shaped current understanding of this fundamental protein-protein interaction, and continues to inspire the search for new drug therapies. However, sequence specificity beyond the LXXLL motif and the molecular functioning of flanking residues still requires urgent addressing. Here, ribosome display has been used to reassess the estrogen receptor for new and enlarged peptide recognition motifs, leading to the discovery of a potent and highly evolved PXLXXLLXXP binding consensus. Molecular modeling and X-ray crystallography studies have provided the molecular insights on the role of the flanking prolines in priming the length of the α-helix and enabling optimal interactions of the α-helix dipole and its surrounding amino acids with the surface charge clamp and the receptor activation function 2. These findings represent new structural parameters for modulating the nuclear receptor-coactivator interaction based on linear sequences of proteinogenic amino acids and for the design of chemically modified inhibitors.
PubMed: 23437920
DOI: 10.1021/ja311748r
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.3 Å)
構造検証レポート
Validation report summary of 4j26
検証レポート(詳細版)ダウンロードをダウンロード

246905

件を2025-12-31に公開中

PDB statisticsPDBj update infoContact PDBjnumon